Form 8-K - Current report:
SEC Accession No. 0001437749-25-000930
Filing Date
2025-01-13
Accepted
2025-01-13 08:09:00
Documents
15
Period of Report
2025-01-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20250112_8k.htm   iXBRL 8-K 29145
2 EXHIBIT 99.1 ex_764827.htm EX-99.1 10982
  Complete submission text file 0001437749-25-000930.txt   182122

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA wint-20250108.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20250108_def.xml EX-101.DEF 11807
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20250108_lab.xml EX-101.LAB 15858
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20250108_pre.xml EX-101.PRE 12022
17 EXTRACTED XBRL INSTANCE DOCUMENT wint20250112_8k_htm.xml XML 2937
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 25524919
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)